184 related articles for article (PubMed ID: 17696568)
1. Impact of weight-loss medications on the cardiovascular system: focus on current and future anti-obesity drugs.
Drolet B; Simard C; Poirier P
Am J Cardiovasc Drugs; 2007; 7(4):273-88. PubMed ID: 17696568
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of current and future anti-obesity drugs.
Comerma-Steffensen S; Grann M; Andersen CU; Rungby J; Simonsen U
Curr Vasc Pharmacol; 2014 May; 12(3):493-504. PubMed ID: 24846238
[TBL] [Abstract][Full Text] [Related]
4. A risk-benefit assessment of anti-obesity drugs.
Kolanowski J
Drug Saf; 1999 Feb; 20(2):119-31. PubMed ID: 10082070
[TBL] [Abstract][Full Text] [Related]
5. Next generation of weight management medications: implications for diabetes and CVD risk.
Wharton S; Serodio KJ
Curr Cardiol Rep; 2015 May; 17(5):35. PubMed ID: 25894803
[TBL] [Abstract][Full Text] [Related]
6. Do we need anti-obesity drugs?
Hainer V; Hainerová IA
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():8-20. PubMed ID: 23280861
[TBL] [Abstract][Full Text] [Related]
7. Drug treatment of obesity in cardiovascular disease.
Charakida M; Finer N
Am J Cardiovasc Drugs; 2012 Apr; 12(2):93-104. PubMed ID: 22292446
[TBL] [Abstract][Full Text] [Related]
8. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.
Krentz AJ; Fujioka K; Hompesch M
Diabetes Obes Metab; 2016 Jun; 18(6):558-70. PubMed ID: 26936802
[TBL] [Abstract][Full Text] [Related]
9. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
Poirier P; Giles TD; Bray GA; Hong Y; Stern JS; Pi-Sunyer FX; Eckel RH
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):968-76. PubMed ID: 16627822
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.
Walter CP; Bleske BE; Dorsch MP
J Clin Pharm Ther; 2014 Oct; 39(5):475-84. PubMed ID: 24924286
[TBL] [Abstract][Full Text] [Related]
11. Safety of drug therapies used for weight loss and treatment of obesity.
Ioannides-Demos LL; Proietto J; Tonkin AM; McNeil JJ
Drug Saf; 2006; 29(4):277-302. PubMed ID: 16569079
[TBL] [Abstract][Full Text] [Related]
12. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.
Poirier P; Giles TD; Bray GA; Hong Y; Stern JS; Pi-Sunyer FX; Eckel RH; ;
Circulation; 2006 Feb; 113(6):898-918. PubMed ID: 16380542
[TBL] [Abstract][Full Text] [Related]
13. Why do we need drugs to treat the patient with obesity?
Bray GA
Obesity (Silver Spring); 2013 May; 21(5):893-9. PubMed ID: 23520198
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Approaches in the Treatment and Maintenance of Weight Loss.
Van Gaal L; Dirinck E
Diabetes Care; 2016 Aug; 39 Suppl 2():S260-7. PubMed ID: 27440841
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
[TBL] [Abstract][Full Text] [Related]
16. Update on obesity pharmacotherapy.
Bray GA; Ryan DH
Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701
[TBL] [Abstract][Full Text] [Related]
17. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
[TBL] [Abstract][Full Text] [Related]
18. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
19. Shedding light on weight loss: A narrative review of medications for treating obesity.
Darapaneni H; Lakhanpal S; Chhayani H; Parikh K; Patel M; Gupta V; Anamika F; Munjal R; Jain R
Rom J Intern Med; 2024 Mar; 62(1):3-11. PubMed ID: 37752761
[TBL] [Abstract][Full Text] [Related]
20. Interface between pharmacotherapy and genes in human obesity.
O'Connor A; Swick AG
Hum Hered; 2013; 75(2-4):116-26. PubMed ID: 24081227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]